Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by jojomarchon Feb 21, 2018 9:05am

88 Views

Post# 27592777

RE:RE:Money

Vestor your analysis brings a lot of insight to this bullboard . A lot of logic accompanies your strategic guess . It only makes sense that if FROST is a major shareholder of TLT and has the big American urology team , a deal will be struck to help TLT reach commercialization . TLT can then work on other indications ( i.e. Lung and GBM ) and build tremendous value for its shareholders . So step 1 is a multi centre Ph2 NMIBC trials with FROST as a partner .

Cheers

Bullboard Posts

This junior mining stock offers billions in market exposure